Armelle Prévost-Blondel (Armelle Prevost-Blondel)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

European journal of immunology

Oncoimmunology

Cancer immunology, immunotherapy : CII

Cell research

This page only lists publications with an associated author ORCID identifier.

Publications

Fériel Bekkat, Malvina Seradj, Renée Lengagne, Frédéric Fiore, Masashi Kato, Bruno Lucas, Flavia Castellano, Valérie Molinier-Frenkel, Yolande Richard, Armelle Prévost-Blondel
Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties. European journal of immunology 54 (4) (2024)
Fériel Bekkat, Malvina Seradj, Renée Lengagne, Frédéric Fiore, Masashi Kato, Bruno Lucas, Flavia Castellano, Valérie Molinier-Frenkel, Yolande Richard, Armelle Prévost-Blondel
Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties. European journal of immunology 54 (4) (2024)
Fériel Bekkat, Malvina Seradj, Renée Lengagne, Frédéric Fiore, Masashi Kato, Bruno Lucas, Flavia Castellano, Valérie Molinier-Frenkel, Yolande Richard, Armelle Prévost-Blondel
Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties. European journal of immunology 54 (4) (2024)
Fériel Bekkat, Malvina Seradj, Renée Lengagne, Frédéric Fiore, Masashi Kato, Bruno Lucas, Flavia Castellano, Valérie Molinier-Frenkel, Yolande Richard, Armelle Prévost-Blondel
Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor properties. European journal of immunology (2024)
Fany Blanc, Nicolas Bertho, Guillaume Piton, Jean-Jacques Leplat, Giorgia Egidy, Emmanuelle Bourneuf, Silvia Vincent-Naulleau, Armelle Prévost-Blondel
Deciphering the immune reaction leading to spontaneous melanoma regression: initial role of MHCII + CD163 - macrophages. Cancer immunology, immunotherapy : CII (2023)
Flavia Castellano, Armelle Prévost-Blondel, José L Cohen, Valérie Molinier-Frenkel
What role for AHR activation in IL4I1-mediated immunosuppression ? Oncoimmunology 10 (1) (2021)
Nicolas Jacquelot, Takahiro Yamazaki, Maria Paula Roberti, Connie P M Duong, Miles C Andrews, Loic Verlingue, Gladys Ferrere, Sonia Becharef, Marie Vétizou, Romain Daillère, Meriem Messaoudene, David P Enot, Gautier Stoll, Stefano Ugel, Ilaria Marigo, Shin Foong Ngiow, Aurélien Marabelle, Armelle Prévost-Blondel, Pierre-Olivier Gaudreau, Vancheswaran Gopalakrishnan, Alexander M Eggermont, Paule Opolon, Christophe Klein, Gabriele Madonna, Paolo Antonio Ascierto, Antje Sucker, Dirk Schadendorf, Mark J Smyth, Jean-Charles Soria, Guido Kroemer, Vincenzo Bronte, Jennifer A Wargo, Laurence Zitvogel
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade. Cell research 29 (10) (2019)
Laetitia Douguet, Lloyd Bod, Laura Labarthe, Renée Lengagne, Masashi Kato, Isabelle Couillin, Armelle Prévost-Blondel
Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma. Oncoimmunology 7 (9) (2018)
Lloyd Bod, Laetitia Douguet, Cédric Auffray, Renée Lengagne, Fériel Bekkat, Elena Rondeau, Valérie Molinier-Frenkel, Flavia Castellano, Yolande Richard, Armelle Prévost-Blondel
IL-4-Induced Gene 1: A Negative Immune Checkpoint Controlling B Cell Differentiation and Activation. Journal of immunology (Baltimore, Md. : 1950) 200 (3) (2017)

Armelle Prévost-Blondel.css-eqlu8i{font-size:small;padding-left:4px;} (Armelle Prevost-Blondel)

Publication Activity (10 Years)

Top Topics

Top Venues

Armelle Prévost-Blondel (Armelle Prevost-Blondel)